Adaptive Biotechnologies Corporation (ADPT) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Adaptive Biotechnologies Corporation, updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Adaptive Biotechnologies Corporation (ADPT) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $4.4B. It trades at $28.37, up 2.57% today. Its overall quality score is 49 out of 100, ranked against the whole US market. 9 analysts' average target of $31.07 implies +9.5% from today's price. Kronos AI's 30-day forecast is −28.7% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $31.07 |
| Low – high | $27.00 – $35.00 |
| Analysts | 9 |
| Upside to average | +9.5% |
Kronos AI 30-day forecast
| Expected close | $19.72 (−28.7%) |
| Likely range | −36.5% … −16.6% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 36 |
| Solvency | 35 |
| Growth | 75 |
| Overall | 49 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator